Drug Detail

Drug Name Temozolomide
Trade Name Temodar
Synonyms Methazolastone
Drug Descriptions

Temodar (temozolomide) is a dacarbazine analog and cytotoxic alkylating agent (NCI Drug Dictionary).

DrugClasses Chemotherapy - Alkylating 14

Filtering

  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"

Sorting

  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Therapy Description
Temozolomide + Irinotecan
E7016 + Temozolomide
Bevacizumab + Erlotinib + Temozolomide
Alisertib + Irinotecan + Temozolomide
Cannabidiol + Temozolomide
Irinotecan + Naxitamab + Sargramostim + Temozolomide
Olaparib + Temozolomide
NSC666715 + Temozolomide
Pazopanib + Temozolomide
Radiotherapy + Temozolomide + Pembrolizumab
Neratinib + Temozolomide
Plerixafor + Temozolomide Mozobil (plerixafor) inhibits CXCR4 and CXCL12-mediated cell signaling to influence tumor metastasis (PMID: 19641136, PMID: 16815309).
Iniparib + Radiotherapy + Temozolomide
Temozolomide + Valproic acid
Temozolomide + Trastuzumab emtansine
Olaparib + Temozolomide + SN-38
Temozolomide Temodar (temozolomide) is a dacarbazine analog and cytotoxic alkylating agent (NCI Drug Dictionary).
GNF-4256 + Irinotecan + Temozolomide
Vincristine + Irinotecan + Temozolomide
NMS-P118 + Temozolomide
Veliparib + Temozolomide
Pazopanib + Irinotecan + Temozolomide
Sunitinib + Temozolomide
Mebendazole + Vincristine + Carboplatin + Temozolomide
Entinostat + Temozolomide
Temozolomide + Irinotecan + Bevacizumab
Abraxane + Temozolomide + Bevacizumab
Pembrolizumab + Temozolomide + Vitespen
Cemiplimab + INO-5401 + INO-9012 + Temozolomide
FANG vaccine + Irinotecan + Temozolomide
Nab-Rapamycin + Temozolomide + Irinotecan
Talazoparib + Temozolomide
Erlotinib + Temozolomide
NU6027 + Temozolomide
pp65 Dendritic Cell Vaccine + Temozolomide
Bortezomib + Temozolomide
Capecitabine + Veliparib + Temozolomide
Decitabine + Temozolomide + Panobinostat
O6-benzylguanine + Temozolomide
M7824 + Temozolomide
CTO + Temozolomide
Rucaparib + Temozolomide
AZ64 + Irinotecan + Temozolomide
Pembrolizumab + Temozolomide
Bevacizumab + Capecitabine + Temozolomide
MK-1775 + Temozolomide
Pamiparib + Temozolomide
Depatuxizumab mafodotin + Temozolomide + Radiotherapy
BKM120 + Temozolomide
NSC124854 + Temozolomide
RIST
E7449 + Temozolomide
Temozolomide + TG02
pp65 Dendritic Cell Vaccine + Temozolomide + Varlilumab Pp65 dendritic cell vaccine is a cancer vaccine composed of autologous dendritic cells modified to express pp65, which potentially results in increased immune response against pp65-expressing tumors (PMID: 25762141, PMID: 28411277).
Lapatinib + Temozolomide
Ruxolitinib + Temozolomide
Temozolomide + TRC102
Vandetanib + Temozolomide
Radiotherapy + RO4929097 + Temozolomide
Nab-Rapamycin + Temozolomide
CEP-9722 + Temozolomide
Bevacizumab + Temozolomide
Oblimersen + Temozolomide + nab-paclitaxel
Niraparib + Temozolomide
Bevacizumab + Bortezomib + Temozolomide
Atezolizumab + Temozolomide
BMX-001 + Temozolomide
Abemaciclib + Temozolomide
PAC-1 + Temozolomide
SLC-0111 + Temozolomide
Bevacizumab + Irinotecan + SGT-53 + Temozolomide
Temozolomide + Etoposide
Nivolumab + Temozolomide
Temozolomide + Etoposide + Doxil + Dexamethasone + Ibrutinib
Vincristine + Doxorubicin + Cyclophosphamide + Ifosfamide + Etoposide + others
SEN-450 + Temozolomide
Carmustine + Filgrastim + Plerixafor + Temozolomide
RRx-001 + Temozolomide
AZD2461 + Temozolomide
Irinotecan + MLN4924 + Temozolomide
Pembrolizumab + Temozolomide + Vorinostat
Bavituximab + Temozolomide
Ibrutinib + Temozolomide